When the wish and the erection don’t match
How might PT-141 affect your interest in sex?
You can still want sex when getting an erection becomes difficult. The main tests concerned women's distress over having little interest in sex.
What separates desire from getting an erection?
An erection problem doesn't necessarily mean you've lost your interest in sex. A loss of desire means the wish itself has faded or gone.
PT-141 reaches cells inside your brain that help create that wish, instead of increasing circulation. The drug acts at receptors, places on cells that respond to certain substances.
A receptor can act like a switch, starting activity when a substance reaches it. Researchers tested whether PT-141 helped women regain some desire through that action.
Related cell switches affect hunger and the production of skin color too. That wider reach helps explain effects beyond the return of sexual interest.
You need to separate a lost wish for sex from difficulty getting firm erections. Evidence for one problem doesn't automatically establish help for the other.
Where in the brain does the drug act?
Brain cells respond to natural substances through switches with the name melanocortin [1]. PT-141 copies the action of a substance your body already makes.
The main switch for this effect is called the melanocortin 4 receptor [1]. A related switch, the melanocortin 3 receptor, plays a smaller part.
Your brain has both switches in areas involved in feelings and the wish to act. That location explains why the research focused on interest in sex instead of circulation.
The natural substance comes from a protein, material your body makes for several jobs [1]. Small parts of that protein form the substance that activates these brain switches.
The natural substance breaks down quickly, while PT-141's closed-loop shape lasts longer [1] [11]. That difference made shots possible, but you still need studies to learn how women benefited.
Did animal tests show more desire or more pleasure?
Wanting sex and enjoying sex aren't quite the same experience for you. Researchers think PT-141 affects brain activity that starts the wish for sex [1] [11].
Female rats receiving the drug approached males more than rats without it [2]. Their back-arching during mating and their movement in general stayed the same.
In female mice, tests tied activity in particular brain cells to accepting mating [6]. These findings concern animal behavior, rather than anyone describing how sex felt.
In 2025, researchers examined enjoyment of sex in female Syrian hamsters [14]. After mating, would treated hamsters show more interest in returning to that place?
The treated hamsters weren't more drawn back, so no increase in enjoyment was shown. Researchers watched where the animals chose to spend time after mating.
Those results suggest that seeking sex and finding sex rewarding involve different brain work. The animal findings gave no evidence that the drug made sex more pleasurable.
What changed on scans when women looked at sexual images?
Women can tell researchers about desire while scans measure their brain activity. This study included 31 women still having periods and troubled by lost interest.
Each woman tried both bremelanotide and a placebo, a treatment containing no active medicine [5]. Neither the women nor the staff knew which treatment came first.
Desire was higher for up to 24 hours after the drug [5]. During sexual-image viewing, scans showed stronger connections between areas handling feelings and bodily sensations.
The viewing task also brought changes in the activity of areas controlling movement. That finding didn't establish better movement or a more satisfying sexual experience.
The scans connect women's reported desire with measurable changes inside their brains. You can see an effect within the brain without learning how pleasure felt.
How can the same drug affect desire, appetite, and skin?
Substances your body makes can activate related cell switches with several different jobs [1]. These switches share the name melanocortin, though they carry out different work.
PT-141 chiefly reaches the brain switches taking part in the desire for sex [1]. Their activity helps explain the reason for testing the drug in women with low interest.
The same group includes switches involved in eating and producing skin color [11]. You may therefore hear about less appetite or darker patches alongside changes in desire.
The appetite and skin findings describe how those effects appeared in studies. You can feel effects beyond sexual interest when the drug reaches these switches.
Why would a desire drug differ from an erection drug?
This is the distinction that defines the compound, so it is worth drawing sharply. PDE-5 inhibitors — the standard erection medicines — act peripherally, on vascular smooth muscle, to improve erectile blood flow; they are plumbing for an event already wanted [1]. PT-141 acts centrally, on the neural circuitry of sexual motivation; it addresses the wanting, not the plumbing [1] [11].
The two mechanisms are not variants of one idea; they are different acts in different places. That is why PT-141 was pursued for low desire — a brain-level problem a vasodilator cannot reach — and why it offered, on paper, something genuinely new in sexual medicine [10] [11].
For a reader moving from mechanism to access, PT-141 belongs in prescription-only care through a licensed clinician; Promise Peptides (mypromise.com) is one route within that category, not the source of the evidence weighed on this page.
How long does PT-141 last after desire changes?
An effect can last beyond the time when medicine in blood is highest. Researchers asked women about desire and separately measured medicine circulating in blood.
The official leaflet describes medicine entering through shots given below the skin [11]. Levels increase following treatment, then drop as your body starts clearing the medicine.
The women having brain scans felt more desire lasting up to 24 hours [5]. That finding describes those women, without guaranteeing the same length of effect for you.
Researchers link the longer effect to changes in how brain cells work together. A falling blood level therefore needn't mean desire returns immediately to its earlier level.
The PT-141 half-life measures how long blood levels take to reach half their earlier amount. The PT-141 dosage page explains that measurement and the studies it came from.
Does PT-141 increase testosterone when desire rises?
Your body uses hormones such as testosterone to help control work in different organs. PT-141 doesn't directly increase testosterone or replace that hormone [1].
The drug doesn't make glands, the organs producing hormones, release more of them [1] [11]. If you felt more desire, that wouldn't show that your testosterone had risen.
What happened to eating and weight in PT-141 tests?
Feeling hungry depends partly on brain activity as well as your empty stomach. PT-141 reaches a brain switch involved in controlling your appetite [11].
Stage 1 means early tests; people with obesity ate less, and their weight fell. A 15-day experiment used shots containing up to 2.5 milligrams of medicine [11].
Researchers sometimes gave treatment three times daily while examining the effect on eating. That frequent use belonged to an experiment, rather than an approved weight treatment.
The medicine has no approval for helping people lose weight [11]. The tests showed changed eating, but didn't establish weight treatment that you could rely on.
What do users say about the wait and length of effects?
A wait before noticing any change comes up in people's accounts of their own use. Some describe interest in sex continuing into the next day after a shot.
These people call their use research, but controlled studies haven't checked their accounts. Their descriptions don't establish when an effect would start or stop for you.
A separate women's study measured an up-to-24-hour period of higher desire [5]. That measured result can't confirm the timing described by people using the drug themselves.
The PT-141 side effects page includes those personal accounts alongside study findings about discomfort. You can see which experiences were checked in studies and which weren't.